Skip to content

Drug interactions

Linagliptin + Rucaparib

Severity: Minor

Linagliptin and Rucaparib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rucaparib inhibits CYP3A4 weakly to moderately and might increase linagliptin exposure. Because most linagliptin is eliminated unchanged, the effect is expected to be small.

What this interaction means in plain words

Linagliptin and Rucaparib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Linagliptin belongs to Endocrine; Rucaparib belongs to Oncology.

Evidence level: Low

Why it happens

CYP3A4 inhibition by rucaparib reduces the minor metabolic clearance of linagliptin.

What to do

No routine dose change; monitor for hypoglycemia and adverse effects if other antidiabetic drugs are co-prescribed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Linagliptin and Rucaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Linagliptin with Rucaparib?

MediHelp rates the interaction as minor. Linagliptin and Rucaparib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Rucaparib inhibits CYP3A4 weakly to moderately and might increase linagliptin exposure. Because most linagliptin is eliminated unchanged, the effect is expected to be small.

How serious is the interaction between Linagliptin and Rucaparib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change; monitor for hypoglycemia and adverse effects if other antidiabetic drugs are co-prescribed.

What other medicines interact with Linagliptin?

MediHelp also lists interactions of Linagliptin with, for example, Alogliptin-pioglitazone, Amlodipine-benazepril, Amobarbital. The full list is on the Linagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in